• Cardiology, Diabetes & Nephrology
    • Cardiology, Diabetes & Nephrology – London
    • Cardiology, Diabetes & Nephrology – Brazil
    • Cardiology, Diabetes & Nephrology – Canada
    • Cardiology, Diabetes & Nephrology – USA
    • Hatter Horizon Series
    • The 18th Malvern Diabetic Foot Conference
    • Previous Events
      • CDNATL 2019 – London
      • CDNATL 2019 – Brazil
      • CDNATL 2018
      • CDNATL 2017
      • CDNATL 2016
      • CDNATL 2015
      • CDNATL 2014
      • CDATL 2013
      • CDATL 2012
      • NATL 2012
      • CDATL 2011
      • CDATL 2010
      • NATL 2010
      • CATL 2009
      • NATL 2009
  • Cell Therapy
    • Cell Therapy at the Limits 2021
  • Oncology
    • Previous Events
      • Accelerating Cancer Immunotherapy 2017
      • OATL 2016
      • OATL 2015
      • OATL 2014
      • OATL 2012
      • OATL 2011
      • OATL 2010
      • UCL Frontiers of Oncology 2019
        • Haematology
        • Melanoma
        • Urology
        • Women’s Health
        • Lung Cancer
        • Gastrointestinal Oncology
  • Multiple Sclerosis
    • Multiple Sclerosis at the Limits 2021
    • Multiple Sclerosis Nurses at the Limits 2021
    • Previous events
      • Multiple Sclerosis at the Limits 2020
      • Multiple Sclerosis Nurses at the Limits 2020
      • Multiple Sclerosis Nurses at the Limits 2019
      • MSATL 2018: Introduction
      • MSATL 2017: Introduction
  • About
    • Academic Founders
    • Independence
    • The Lancet
    • Support & Sponsorship
    • Delegate Invitations
  • Supporters
  • Archive
    • CDNATL 2019 – London
    • CDNATL 2019 – Brazil
    • Multiple Sclerosis at the Limits 2018
    • Multiple Sclerosis at the Limits 2020
    • Multiple Sclerosis Nurses at the Limits 2020
    • Multiple Sclerosis Nurses at the Limits 2019
    • Hatter Horizon Series
      • Horizon GP Programme 2019
      • Hatter Horizon Series 2019
      • Hatter Horizon Series 2018
      • Hatter Horizon Series 2017
    • Cardiology, Diabetes & Nephrology at the Limits 2018
    • Accelerating Cancer Immunotherapy 2017
    • Oncology at the Limits 2017

Professor Paul Zimmet

Professor Paul Zimmet is Professor of Diabetes, Monash University and Director Emeritus, Baker IDI Heart and Diabetes Institute, and Honorary President of the International Diabetes Federation. He has an outstanding international record in diabetes and obesity research, particularly in epidemiology and public health, research that predicted then charted the evolving global type 2 diabetes epidemic. His genetic studies with Professor Greg Collier, at Deakin University and epigenetic research at Baker IDI Monash with Professor Assam El Osta have led to important understanding of mechanisms in diabetes and obesity. He co-led the  Monash team to develop the first laboratory anti-GAD test for predicting type 1 diabetes, now used throughout the world. He has published over 890 papers and listed in both the 2015 and 2016 Thomson Reuter’s “Worlds-Most-Influential-Scientific-Minds”.

His many international and national awards include the Kelly West and Harold Rifkin Medals (American Diabetes Association), the Kellion Award (the highest scientific recognition of the Australian Diabetes Society), Banting Award (Diabetes UK) and the Professor A.M. Cohen Memorial Award and Lecture, EASD in Jerusalem in 2000. In 2010, he received the Grand Hamdan International Prize for Medical Sciences and, in 2013, he was awarded the Peter Wills Medal from Research Australia recognising an Australian who has made an outstanding contribution to building Australia’s international reputation in the area of health and medical research. In 2015, he gave the Howard Florey Memorial Oration at the University of Adelaide and in 2016, he gave the Jeffery Cheah Distinguished Speaker Lecture at Malaysia’s Sunway University. He is Co-Director with Professor Naftali Stern at the newly established Sagol Center for Epigenetics of Metabolism and Aging at the Tel Aviv Medical Center in Tel Aviv.

He is an International Member of the Spanish Royal National Academy of Medicine and holds Honorary Doctorates from Madrid’s Complutense University, Monash University, Tel Aviv University and the University of Adelaide. He is an Officer of the Order of Australia (AO) for distinguished services to medicine, nutrition and the biotechnology industry.  He was Co-Chair of the Australian Government’s National Diabetes Strategy Advisory Committee for the development of the 2016-2020 Strategy.

« Dr Martin Duddy
»

Cardiology, Diabetes & Nephrology at the Limits 2021
Monday, 12 & Tuesday, 13 April 2021, Virtual Meeting

The 18th Malvern Diabetic Foot Conference
Wednesday, 12 – Friday, 14 May 2021, Malvern, UK

Multiple Sclerosis Nurses
at the Limits

Friday, 10 & Saturday, 11 September 2021, London, UK

Multiple Sclerosis at the Limits
Monday, 13 & Tuesday, 14 September 2021, London, UK

Hatter Horizon GP Meeting
Monday, 1 November 2021
London, UK

Cell Therapy at the Limits 2021
Monday, 8 & Tuesday, 9 November 2021, London, UK

Hatter Horizon Series
Monday, 22 November 2021, London, UK

Cardiology, Diabetes & Nephrology at the Limits Brazil
Friday, 10 - Saturday, 11 December 2021, São Paulo, Brazil

Cardiology, Diabetes & Nephrology at the Limits Canada
Tuesday, 24 & Wednesday, 25 May 2022, Toronto, Canada

Policy links

  • Medical Disclaimer
  • Disclosure
  • E-mail Policy
  • Privacy Policy
  • Anti-spam Policy
  • Disclaimer
  • External Links Policy
  • Terms of use
  • Contact
  • The Lancet
  • UCL
  • UCT
  • Brigham & Women’s Hospital
  • The University of Campinas
© 2021 At the Limits Ltd.
This site uses cookies More info